WO2005034891B1 - Composition comprising a rosmarinus officinalis plant extract, a centella, echinacea or alpinia plant extract and a dna repair enzyme - Google Patents

Composition comprising a rosmarinus officinalis plant extract, a centella, echinacea or alpinia plant extract and a dna repair enzyme

Info

Publication number
WO2005034891B1
WO2005034891B1 PCT/US2004/033419 US2004033419W WO2005034891B1 WO 2005034891 B1 WO2005034891 B1 WO 2005034891B1 US 2004033419 W US2004033419 W US 2004033419W WO 2005034891 B1 WO2005034891 B1 WO 2005034891B1
Authority
WO
WIPO (PCT)
Prior art keywords
plant
composition
plant extract
ingredient
alpinia
Prior art date
Application number
PCT/US2004/033419
Other languages
French (fr)
Other versions
WO2005034891A3 (en
WO2005034891A2 (en
Inventor
Amy C Zimmerman
John V Scimeca
Original Assignee
Access Business Group Int Llc
Amy C Zimmerman
John V Scimeca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2006534434A priority Critical patent/JP2007508320A/en
Application filed by Access Business Group Int Llc, Amy C Zimmerman, John V Scimeca filed Critical Access Business Group Int Llc
Priority to PCT/US2005/012033 priority patent/WO2006041526A1/en
Priority to JP2007540294A priority patent/JP2008518042A/en
Priority to TW094111647A priority patent/TWI352600B/en
Publication of WO2005034891A2 publication Critical patent/WO2005034891A2/en
Publication of WO2005034891A3 publication Critical patent/WO2005034891A3/en
Publication of WO2005034891B1 publication Critical patent/WO2005034891B1/en
Priority to US11/399,728 priority patent/US20060257509A1/en
Priority to US11/485,945 priority patent/US7959953B2/en
Priority to US11/784,159 priority patent/US7758878B2/en
Priority to US12/839,202 priority patent/US8697099B2/en
Priority to US14/184,244 priority patent/US8916180B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A61K8/9722—Chlorophycota or Chlorophyta [green algae], e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A cosmetic composition is provided having ingredients that may prevent signs of aging, improve the aesthetic appearance of skin, and promote recovery from environmental stresses. The composition includes natural ingredients, including at least one ingredient or extract from rosemary; at least one ingredient or extract from Centella, Echinacea, Alpinia or mixtures thereof; a DNA repair enzyme; and at least one pharmaceutically or cosmetically acceptable vehicle.

Claims

AMENDED CLAIMS[Received by the International Bureau on 13 June 2005 (13.06.2005) ; original claims 1 - 3 and 9, replaced by amended claim 1 - 3 and 9; original claims 4 - 8 and 10 - 42, unchanged]
1. A topicai composition comprising: a. at least one plant ingredient or plant extract from Rosmarinus officinalis, wherein the plant ingredient or plant extract from Rosmarinus officinalis is selected from the group consisting of plant extract, ursolic acid, carnosic acid, rosrnarinic acid, and oleanolic acid; b. at least one plant ingredient or plant extract from Centella, Echiπacea or Alpinia, wherein the at least one plant ingredient or plant extract from Centella is selected from the group consisting of plant extract, asiatic acid, madecassic acid and asiaticoside; wherein the at least one plant ingredient or plant extract from Ec inacea is selected from the group consisting of plant extract and echiπoside; and wherein the at least one plant ingredient or plant extract from Alpinia is selected from the group consisting of plant extract and diarylheptanoid; c. at least one DNA repair enzyme; and d. at least one pharmaceutically or cosmetically acceptable vehicle.
2. The composition of claim 1, comprising at least one plant ingredient from Rosmarinus officinalis, wherein the at least one plant ingredient from Rosmarinus officinalis is selected from the group consisting of ursolic acid, carnosic acid, rosrnarinic acid, and oleanolic acid,
3. The composition of claim 1 , comprising at least one Rosmarinus officinalis plant extract.
4. The composition of claim 3, where the at least one Rosmarinus officinalis plant extract is present in an amount from about 0.001 to about 10% by weight of the total composition.
5. The composition of any of claims 1-4, comprising at least one Centella plant extract,
6. The composition of any of claims 1-4, comprising a Centella asiatica plant extract
7. The composition of any of claims 1-4, comprising at least one Centella plant extract present in an amount from about 0.001 to about 10% by weight of the total composition,
8. The composition of any of claims 1-4, comprising at least one Echinacea plant ingredient or plant extract.
9. The composition of any of claims 1-4, comprising at least one Echinacea plant ingredient or plant extract, wherein the at least one Echinacea plant ingredient or plant extract is from a species selected from the group consisting of £ purpurea, E, angustifolia, and E. pallida.
10. The composition of any of claims 1-4, comprising at least one Echinacea plant extract is present in an amount from about 0.0001 to about 1% by weight of the total composition.
11. The composition of any of claims 1 -4, comprising at least one Alpinia plant ingredient,
12. The composition of any of claims 1 -4, comprising at least one Alpinia plant extract,
13. The composition of any of claims 1-4, comprising an Alpinia speciosa plant extract.
14. The composition of any of claims 1-4, comprising at least one Alpinia plant extract is present in an amount from about 0.001 to about 10% by weight of the total composition.
15. The composition of claim 1 , comprising plant ingredients or plant extracts selected from at least two members of the group consisting of Centella asiatica, Echinacea angustifolia, and Alpinia speciosa.
16. The composition of claim 1 , comprising plant ingredients or plant extracts from each member of the group consisting of Centella asiatica, Echinacea angustifolia, and Alpinia speciosa.
PCT/US2004/033419 2003-10-10 2004-10-07 Composition comprising a rosmarinus officinalis plant extract, a centella, echinacea or alpinia plant extract and a dna repair enzyme WO2005034891A2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP2006534434A JP2007508320A (en) 2003-10-10 2004-10-07 A composition comprising rosmarinusofficinalis plant extract, Centella, Echinacea or Alpinia plant extract, and DNA repair enzyme
PCT/US2005/012033 WO2006041526A1 (en) 2004-10-07 2005-04-12 Composition comprising a rosmarinus officinalis plant extract, an alpinia plant extract and a dna repair enzyme
JP2007540294A JP2008518042A (en) 2004-10-07 2005-04-12 A composition comprising a rosemary (Rosmarinusofficinalis) plant extract, an Alpinia plant extract, and a DNA repair enzyme.
TW094111647A TWI352600B (en) 2004-10-07 2005-04-13 Cosmetic treatment system and methods
US11/399,728 US20060257509A1 (en) 2003-10-10 2006-04-07 Cosmetic composition and methods
US11/485,945 US7959953B2 (en) 2003-10-10 2006-07-13 Cosmetic composition and methods
US11/784,159 US7758878B2 (en) 2003-10-10 2007-04-05 Cosmetic treatment system and methods
US12/839,202 US8697099B2 (en) 2003-10-10 2010-07-19 Cosmetic treatment system and methods
US14/184,244 US8916180B2 (en) 2003-10-10 2014-02-19 Cosmetic treatment system and methods

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51030703P 2003-10-10 2003-10-10
US60/510,307 2003-10-10

Related Child Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2005/012033 Continuation-In-Part WO2006041526A1 (en) 2003-10-10 2005-04-12 Composition comprising a rosmarinus officinalis plant extract, an alpinia plant extract and a dna repair enzyme
US11/399,728 Continuation US20060257509A1 (en) 2003-10-10 2006-04-07 Cosmetic composition and methods

Publications (3)

Publication Number Publication Date
WO2005034891A2 WO2005034891A2 (en) 2005-04-21
WO2005034891A3 WO2005034891A3 (en) 2005-05-19
WO2005034891B1 true WO2005034891B1 (en) 2005-07-21

Family

ID=34435081

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/033419 WO2005034891A2 (en) 2003-10-10 2004-10-07 Composition comprising a rosmarinus officinalis plant extract, a centella, echinacea or alpinia plant extract and a dna repair enzyme

Country Status (5)

Country Link
US (1) US7959953B2 (en)
JP (1) JP2007508320A (en)
KR (1) KR20060108665A (en)
TW (1) TWI381847B (en)
WO (1) WO2005034891A2 (en)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080124409A1 (en) * 2000-11-21 2008-05-29 Access Business Group International Llc Topical Skin Compositions, Their Preparation, and Their Use
US8835014B2 (en) 2002-10-22 2014-09-16 Allegiance Corporation Coating composition for skin-contacting surface of elastomeric articles and articles containing the same
JP2007508320A (en) 2003-10-10 2007-04-05 アクセス ビジネス グループ インターナショナル エルエルシー A composition comprising rosmarinusofficinalis plant extract, Centella, Echinacea or Alpinia plant extract, and DNA repair enzyme
WO2006041526A1 (en) * 2004-10-07 2006-04-20 Access Business Group International Llc Composition comprising a rosmarinus officinalis plant extract, an alpinia plant extract and a dna repair enzyme
US7758878B2 (en) 2003-10-10 2010-07-20 Access Business Group International Llc Cosmetic treatment system and methods
US20050171194A1 (en) * 2003-12-08 2005-08-04 Yu Ruey J. Enlargement of mucocutaneous or cutaneous organs and sites with topical compositions
JP2008518042A (en) * 2004-10-07 2008-05-29 アクセス ビジネス グループ インターナショナル エルエルシー A composition comprising a rosemary (Rosmarinusofficinalis) plant extract, an Alpinia plant extract, and a DNA repair enzyme.
WO2007021240A1 (en) * 2005-08-18 2007-02-22 Tricutan Ab New skin improving composition
CN101304755A (en) * 2005-11-09 2008-11-12 拜耳消费者保健股份公司 Use of compounds from centella asiatica
FR2893252B1 (en) 2005-11-17 2008-02-15 Engelhard Lyon Sa VEGETABLE EXTRACTS STIMULATING HAS2
US20080020023A1 (en) * 2006-07-20 2008-01-24 Shiping Wang Nonaqueous coating composition for elastomeric articles and articles containing the same
US20080138393A1 (en) * 2006-12-11 2008-06-12 Access To Business Group International Llc Water soluble extract of spinach for prevention and repair of DNA damage
WO2008089408A1 (en) * 2007-01-18 2008-07-24 Pinsky Mark A Materials and methods for delivering antioxidants into the skin
JP2008184441A (en) * 2007-01-30 2008-08-14 B & C Laboratories Inc External preparation for skin for promoting fibroblast proliferation
US8193155B2 (en) * 2009-02-09 2012-06-05 Elc Management, Llc Method and compositions for treating skin
US20090047309A1 (en) * 2007-08-13 2009-02-19 Maes Daniel H Cosmetic methods and compositions for repairing human skin
US8703161B2 (en) 2007-08-13 2014-04-22 Elc Management, Llc Skin repair compositions comprising circadian gene activators and a synergistic combination of Sirt1 gene activators
PL2191825T3 (en) 2007-08-27 2016-11-30 Agent for fungal dermatitis
DE102008014289A1 (en) 2008-03-11 2009-09-17 Coty Prestige Lancaster Group Gmbh Cosmetic with anti-aging effect
WO2009151057A1 (en) * 2008-06-09 2009-12-17 国立大学法人東京農工大学 Process for production of antioxidant active substance
FR2932986B1 (en) * 2008-06-26 2010-12-10 Michele Evrard REGENERATING COMPOSITION OF THE SKIN
KR101763334B1 (en) 2008-07-22 2017-07-31 이준 파마슈티컬스, 인코포레이티드 Topical Anti-Inflammatory Combination
JP2010065014A (en) * 2008-09-12 2010-03-25 Tokyo Univ Of Agriculture & Technology Anti-propionibacterium compound and production thereof
US9445975B2 (en) 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
JP5376891B2 (en) * 2008-10-03 2013-12-25 丸善製薬株式会社 Filaggrin production promoter
KR101011356B1 (en) * 2008-12-02 2011-01-28 한불화장품주식회사 A stick type cosmetic compound containing rosmarinic acid
CH698274B1 (en) * 2008-12-12 2009-06-30 Labo Cosprophar Ag Complex of active plant stem cells and cosmetic composition.
FR2939683B1 (en) * 2008-12-17 2012-04-20 Oreal COSMETIC COMPOSITION COMPRISING A BRANCHED SULFONIC POLYESTER AND A PARTICULAR SURFACTANT AND USES THEREFOR
US8911774B2 (en) * 2009-05-18 2014-12-16 Cellhealth Technologies Ltd. Topical composition for anti-aging skin treatment using dual DNA repair mechanism and method of use
JP5770428B2 (en) * 2010-03-09 2015-08-26 株式会社コーセー Singlet oxygen scavenger, skin external preparation and cosmetic using the singlet oxygen scavenger
JP2011195539A (en) * 2010-03-23 2011-10-06 Kose Corp Elastase activity inhibitor
US20110280850A1 (en) * 2010-05-12 2011-11-17 Starr Elizabeth I Compositions Containing DNA Repair Enzyme And Anogeissus Extract
US20120035557A1 (en) 2010-07-16 2012-02-09 Timothy Woodrow Coffindaffer Personal Care Compositions Comprising A Multi-Active System For Down Regulating Cytokines Irritation
US20120237494A1 (en) * 2010-09-30 2012-09-20 Daly Susan M Compositions Containing Zinc PCA And Anogeissus Extract
US8383167B2 (en) * 2011-03-08 2013-02-26 Elc Management, Llc Method for cosmetically treating caspase-14 deficiency
JP5687170B2 (en) 2011-03-30 2015-03-18 コスメディ製薬株式会社 Microneedle patch storage container
MX356540B (en) * 2011-05-10 2018-06-01 Mary Kay Inc Cosmetic compositions.
KR101358718B1 (en) * 2011-06-10 2014-02-10 연세대학교 산학협력단 Cosmetic composition which has ricinus communis l. extract and sophora japonica flower extract as active components, and improves cellulite
WO2013025893A1 (en) 2011-08-16 2013-02-21 The Gillette Company Personal care compositions comprising an anti-irritation agent
ES2754050T3 (en) * 2011-10-11 2020-04-15 Elc Man Llc Method and compositions for treating the skin
KR101308895B1 (en) * 2011-11-24 2013-09-24 주식회사 에이블씨엔씨 Powder makeup cosmetic composition comprising spherical powder encapsulated with saccharomyces lysate extract and 10 organic farming ingredients having anti-aging and skin moisturizing effect
KR101361569B1 (en) * 2012-06-18 2014-02-13 주식회사 루트로닉 Ｃｏｓｍｅｔｉｃ ｃｏｍｐｏｓｉｔｉｏｎ ｆｏｒ ｔｈｅ ｃａｌｍｉｎｇ ａｎｄ ａｐｐｌｙｉｎｇ ａｎ ｅｌｅｃｔｒｉｃ ｃｕｒｒｅｎｔ ｏｆ ｓｋｉｎｓ ａｎｄ ｍａｎｕｆａｃｔｕｒｉｎｇ ｔｈｅ ｓａｍｅ
CN103635200A (en) * 2012-06-28 2014-03-12 株式会社资生堂 Hyaluronic acid decomposition inhibitor comprising rosemary extract and retinol acetate
EP2872167A4 (en) * 2012-07-12 2015-06-03 Prec Dermatology Inc Topical formulations comprising dna repair enzymes, and methods of use thereof
US10383815B2 (en) 2012-09-14 2019-08-20 Elc Management Llc Method and compositions for improving selective catabolysis in cells of keratin surfaces
US8920855B1 (en) 2012-10-30 2014-12-30 Setem Hemth, Inc Methods of topically treating tinnitus and related disorders
WO2014092682A1 (en) 2012-12-11 2014-06-19 Avon Products, Inc. Serissa japonica extracts and methods of use
US9265716B2 (en) 2012-12-11 2016-02-23 Avon Products, Inc. Hoya carnosa extracts and methods of use
US8865231B2 (en) 2012-12-11 2014-10-21 Avon Products, Inc. Hoya carnosa extracts and methods of use
US9034396B2 (en) 2012-12-11 2015-05-19 Avon Products, Inc. Serissa japonica extracts and methods of use
WO2014163717A1 (en) * 2013-03-11 2014-10-09 Avon Products, Inc. Hoya carnosa extracts and methods of use
WO2014143375A1 (en) * 2013-03-11 2014-09-18 Avon Products, Inc. Serrisa japonica extracts and methods of use
EP2981243B1 (en) 2013-04-02 2019-09-04 Evonik Degussa GmbH Compositions of botanical powder-based delivery systems for personal care products
US10039798B2 (en) 2013-11-13 2018-08-07 In Ingredients, Inc. Extracts of rosemary or hemerocallis fulva and methods of using same to promote circadian rhythm
JP5768114B2 (en) * 2013-11-29 2015-08-26 ポーラ化成工業株式会社 Method for producing an external preparation for aging
US20150164967A1 (en) * 2013-12-12 2015-06-18 Kemin Industries, Inc. Personal Care Products Containing Extracts of Rosemary
US20150164777A1 (en) * 2013-12-12 2015-06-18 Kemin Industries, Inc. Personal Care Products Containing Extracts of Rosemary
CN105813627A (en) * 2013-12-13 2016-07-27 雷斯托尔西有限公司 Exfoliative hair retention-promoting formulation
US20160069867A1 (en) 2014-09-04 2016-03-10 Shiseido Company, Ltd. Method for screening skin barrier function enhancing agent based on epidermal serine racemase and/or d-serine level, and skin barrier function evaluation method
TWI666444B (en) * 2014-03-05 2019-07-21 日商資生堂股份有限公司 Screening method for skin barrier function promoting agent and skin barrier function evaluation method using epidermal serine racemase and/or D-serine amount as indicators
JP2017515861A (en) 2014-05-16 2017-06-15 レスターシー エルエルシイＲｅｓｔｏｒｓｅａ， Ｌｌｃ Biphasic cosmetics
KR102274295B1 (en) * 2014-07-23 2021-07-07 주식회사 엘지생활건강 Composition for applying to skin externally
JP6522552B2 (en) * 2016-06-17 2019-05-29 イーエルシー マネージメント エルエルシー Methods and compositions for treating skin
US10154955B2 (en) 2016-07-01 2018-12-18 Access Business Group International Llc Compositions including bauhinia, methods of making and using the same in skin anti-aging and other skin applications
EP3817755A4 (en) 2018-07-03 2022-04-20 Mary Kay Inc. Topical muscle relaxation compositions and methods

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077211A (en) 1988-07-06 1991-12-31 Applied Genetics, Inc. Purification and administration of dna repair enzymes
EP0707844A3 (en) * 1994-10-20 1998-01-28 California Suncare Inc. Liposome delivery of compositions to enhance tanning and repair UV damage
US5939082A (en) * 1995-11-06 1999-08-17 The Procter & Gamble Company Methods of regulating skin appearance with vitamin B3 compound
FR2746316B1 (en) * 1996-03-19 1998-06-12 Guerlain NEW COSMETOLOGICAL OR DERMATOLOGICAL COMPOSITIONS
JPH1045559A (en) * 1996-08-06 1998-02-17 Eikoudou:Kk Cosmetic
US6479533B1 (en) 1997-02-20 2002-11-12 Applied Genetics Incorporated Dermatics Methods and compositions for the protection of mitochondria
US5935596A (en) * 1997-03-20 1999-08-10 Chesebrough-Pond's Usa Co. Delivery of skin benefit agents via adhesive strips
US6660283B2 (en) 1997-12-19 2003-12-09 Societe L'oreal S.A. Use of cinnamic acid, or of at least one of its derivatives in a cosmetic composition
FR2772612B1 (en) 1997-12-19 2003-01-10 Oreal USE OF CINNAMIC ACID OR DERIVATIVES THEREOF IN A FIRMING COSMETIC COMPOSITION
FR2781670B1 (en) 1998-07-30 2001-09-07 Oreal COSMETIC OR PHARMACEUTICAL PATCH AND ITS PACKAGING
FR2788435B1 (en) * 1999-01-15 2002-08-02 Oreal USE OF AN EXTRACT OF A PLANT OF THE GENUS ROSMARINUS IN COMPOSITIONS FOR TREATING SKIN SIGNS OF AGING
US6267671B1 (en) * 1999-02-12 2001-07-31 Mikohn Gaming Corporation Game table player comp rating system and method therefor
JP3741569B2 (en) * 1999-07-06 2006-02-01 ポーラ化成工業株式会社 Cosmetics for maintaining and improving forms
ES2154243B1 (en) * 1999-09-10 2001-11-16 Zarauza Luisa Pasarin CREAM FOR HANDS AND NAILS.
US6723548B2 (en) * 2000-05-23 2004-04-20 Board Of Regents, The University Of Texas System DNA repair polypeptides and methods of use
DE10063433A1 (en) * 2000-12-20 2002-06-27 Henkel Kgaa Use of DNA repair enzymes as MMP-1 inhibitors
US6589514B2 (en) 2001-04-17 2003-07-08 Morinda, Inc. Cosmetic intensive repair serum with morinda citrifolia
JP2003095912A (en) * 2001-09-20 2003-04-03 Noevir Co Ltd Skin care preparation
JP2003246722A (en) * 2002-02-25 2003-09-02 Kanebo Ltd Whitening cosmetic
US20030175328A1 (en) 2002-03-06 2003-09-18 Adi Shefer Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin
DE10231468A1 (en) * 2002-07-08 2004-02-26 Coty B.V. Anti-Hautalterungskosmetikum
DE20214753U1 (en) * 2002-09-24 2002-12-12 Hando Handels Ges. M.B.H., Graz Pharmaceutical composition for the treatment and / or prevention of light eruption
KR100489701B1 (en) * 2002-10-09 2005-05-16 주식회사 태평양 Submicron-liposome containing highly concentrated triterpenoid and method for preparing thereof
JP2007508320A (en) 2003-10-10 2007-04-05 アクセス ビジネス グループ インターナショナル エルエルシー A composition comprising rosmarinusofficinalis plant extract, Centella, Echinacea or Alpinia plant extract, and DNA repair enzyme

Also Published As

Publication number Publication date
US20060257386A1 (en) 2006-11-16
KR20060108665A (en) 2006-10-18
TW200526260A (en) 2005-08-16
US7959953B2 (en) 2011-06-14
JP2007508320A (en) 2007-04-05
WO2005034891A3 (en) 2005-05-19
TWI381847B (en) 2013-01-11
WO2005034891A2 (en) 2005-04-21

Similar Documents

Publication Publication Date Title
WO2005034891B1 (en) Composition comprising a rosmarinus officinalis plant extract, a centella, echinacea or alpinia plant extract and a dna repair enzyme
CA2397198A1 (en) Echinacea extract as anti-irritant and anti-aging booster in cosmetic compositions
AU3115097A (en) Methods of regulating skin condition with centella asiatica extract
DK0841899T3 (en) Preparations for topical administration of active ingredients
EP1138314A3 (en) Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
EP1949887A2 (en) Cosmetic formulas for skin smoothing and tautening
TW200611711A (en) Cosmetic treatment system and methods
CA2623777A1 (en) Compositions comprising hypsizygus ulmarius extract
DE60115202T2 (en) COSMETIC SLIMMING MEANS CONTAINING A PLANT EXTRACT WITH A NATURAL PEPTIDE
CN108379168A (en) A kind of cosmetics and preparation method thereof of phytoremediation cuticula
WO2004028550A3 (en) Composition comprising panax ginseng and paullinia cupana extracts
WO2003039442A3 (en) Use of an extract from the vigna aconitifolia plant in a cosmetic and/or dermopharmaceutical composition
PT930888E (en) PHARMACEUTICAL AND COSMETIC FORMULATIONS ANTIACNE CONTAINING EXTRACTS OF PLANTS (KRAMERIA TRIANDRA OR MESUA FERREA)
ID30019A (en) USE OF PLANT EXTRACT WITH ANTI-RADICAL ACTION TYPE
CA2449485A1 (en) Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite
WO2003015724A1 (en) Substances capable of potentiating laminin 5 productivity in epidermal cells and utilization thereof
WO2006018149A1 (en) Cosmetic compositions for treating stressed skin containing taurine and long-chained fatty alcohols
RU2003133289A (en) PHARMACEUTICAL AND COSMETIC COMPOSITIONS AGAINST SKIN AGING
WO2006125049A3 (en) Elastin producing fibroblasts
DE69518655T2 (en) HYDRATION COMPOSITIONS FOR HUMAN OR ANIMAL
CN107334715A (en) Add the propolis facial mask of pilose antler
CN108524368A (en) One kind is except acarid frost
CN108524423A (en) A kind of hypo-allergenic face cream
DE202018101021U1 (en) Means for normalizing hair growth and head condition
FR2411605A1 (en) Slimming cosmetic compsns. applied to the skin - contg. specified plant extracts, gelling agent and excipient

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
B Later publication of amended claims

Effective date: 20050613

WWE Wipo information: entry into national phase

Ref document number: 2006534434

Country of ref document: JP

Ref document number: 11399728

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 1020067008984

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 1020067008984

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 11399728

Country of ref document: US

122 Ep: pct application non-entry in european phase